Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists
{{output}}
Aims: To evaluate the determinants of cardiovascular (CV) protection in men and women treated with glucagon-like peptide-1 receptor agonists (GLP1-RA). Methods: ... ...
